These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32840331)

  • 21. Early identification and treatment of Alzheimer's disease: social and fiscal outcomes.
    Weimer DL; Sager MA
    Alzheimers Dement; 2009 May; 5(3):215-26. PubMed ID: 19362885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicted economic damage from a quick, simple Alzheimer's disease cure.
    Norins LC
    Med Hypotheses; 2019 Dec; 133():109398. PubMed ID: 31539811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2015 Alzheimer's disease facts and figures.
    Alzheimer’s Association
    Alzheimers Dement; 2015 Mar; 11(3):332-84. PubMed ID: 25984581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacoeconomics of Alzheimer's disease.
    Fillit HM
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1139-44; discussion S1145-8. PubMed ID: 11142178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How much does it really cost to care for persons with Alzheimer's disease?
    Brummel-Smith K
    J Am Geriatr Soc; 2001 Sep; 49(9):1255-6. PubMed ID: 11559389
    [No Abstract]   [Full Text] [Related]  

  • 27. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
    Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
    Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.
    Deb A; Thornton JD; Sambamoorthi U; Innes K
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):189-202. PubMed ID: 28351177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major Cost Drivers in Assessing the Economic Burden of Alzheimer's Disease: A Structured, Rapid Review.
    Kosaner Kließ M; Martins R; Connolly MP
    J Prev Alzheimers Dis; 2021; 8(3):362-370. PubMed ID: 34101795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost of dementia in Medicare managed care: a systematic literature review.
    Fishman P; Coe NB; White L; Crane PK; Park S; Ingraham B; Larson EB
    Am J Manag Care; 2019 Aug; 25(8):e247-e253. PubMed ID: 31419102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2009 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2009 May; 5(3):234-70. PubMed ID: 19426951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2011 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2011 Mar; 7(2):208-44. PubMed ID: 21414557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
    J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential Impact of Alzheimer's Disease Early Treatment on Societal Costs of Care in Czechia: A Simulation Approach.
    Broulikova HM; Sladek V; Arltova M; Cerny J
    J Ment Health Policy Econ; 2018 Dec; 21(4):147-161. PubMed ID: 30676992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2012 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2012; 8(2):131-68. PubMed ID: 22404854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2008 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2008 Mar; 4(2):110-33. PubMed ID: 18631956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.